event schedule

1st session: Exploration and development of Biologic Drugs and Vaccines
Session Moderator: Prof. Ibrahim Alsarra

• Fundamental of Biologics and Vaccines Discovery and Development (Mazen Hassanain MD, PhD, FACS)
  
  
• The Role of Government and University Research Institutions in The Development of Biological Drugs (Moureq Alotaibi, MS, PhD)

• Saudi NIH Support to Biological Drugs and Vaccines Research (Musaad Alshammari, PhD)

• Cell and Gene Therapy: Transforming Treatment Paradigms in Hematology and Beyond (Bashayer Alshehri, PharmD)

2nd Session 1st Half: Manufacturing of Biologic Drugs and Vaccines
Session Moderator: Dr. Farhan Alshammari

• Future of National Pharmaceutical Industries (Yasser Alobaida, MS, PhD)
  
  
• New Horizon of Vaccines (Mashal Alshazi, PhD)

2nd Session 2nd Half: Manufacturing of Biologic Drugs and Vaccines
Session Moderator: Dr. Farhan Alshammari

• Manufacturing and Regulatory Aspects of pDNA Vaccines for Clinical Trials (Iman Almansour Alzamil, PhD)
  
  
• Integration of Artificial Intelligence (AI) in the Design of Biologic Drugs and Vaccines (Maali D. Alshammari, MS, PhD)

3rd session: Clinical applications and usage of Biologic Drugs and Vaccines
Session Moderator: Dr. Hind Alqwaai

• Anti-angiogenesis Biologics and Antibodies for Cancer Treatment (Constantinos Mikelis, Ph.D)

• Antibody for Cancer Targeting (Taslim Alhilal, Ph.D)

• Application of CPP to Enhance Biological Drug Oral Delivery (Khaled Almansour, Ph.D)

• AI in Biopharma: Upstream and Downstream Applications (Toni Manzano)
  
  
• Clinical Applications of Biologics and Vaccines (Yazed Alsowaida, PharmD, BCPS, BCIDP)

4th Session: Regulations and Legislations Related to Biologic Drugs and Vaccines
Session Moderator: Dr. Sumyah Almarshadi

• Biologics vs. Biosimilars: Key Differences in Regulations and Legislation (Ibrahim Alsarra, MS, PhD)
  
  
• Evolution of Regulation and Assessment of Biotech and Biosimilar Product (Ali Alsamil, MS, PhD)
  
  
• Vaccines Registration Challenges, and their Related Legislation and Regulations (Abdulmajeed Al-Olayet, BS. Pharm, MBA)
  
  
• Difficulties and Challenges of Vaccine Manufacturing and Supply Chains from Raw Materials to the Final Product (Abdulmajeed Al-Olayet, BS. Pharm, MBA)